Boothbay Fund Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Boothbay Fund Management’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20,195	Closed	-$61.6K	–	2003
2023 Q4	$61.6K	Buy	+20,195	New	+$37.9K	﹤0.01%	1507
2023 Q2	–	Sell	-26,300	Closed	-$70.5K	–	2440
2023 Q1	$70.5K	Buy	26,300 +11,139	+73%	+$53.5K	﹤0.01%	1994
2022 Q4	$82.3K	Buy	+15,161	New	+$127K	﹤0.01%	1835
2019 Q3	–	Sell	-35,111	Closed	-$1.11M	–	932
2019 Q2	$1.08M	Buy	+35,111	New	+$739K	0.1%	250

Boothbay Fund Management's GTHX Position: Q1 2024 in Review

Boothbay Fund Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2024, closing a stake of 20,195 shares — an estimated $61.6K sold.

Boothbay Fund Management first reported a position in GTHX in Q2 2019 and held it in 4 quarters. The position peaked at $1.08M in Q2 2019. 86 funds tracked by Wall St. Rank hold GTHX as of Q1 2024.

Boothbay Fund Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Boothbay Fund Management sold 20,195 G1 Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $61.6K.
Boothbay Fund Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2019 and held it in 4 quarters.
Boothbay Fund Management's G1 Therapeutics, Inc. Common Stock position peaked at $1.08M in Q2 2019.
86 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Boothbay Fund Management's 13F filing for Q1 2024, filed 15 May 2024.